Based on the provided content, here's an analysis of CVE-2021-31562:

**Root Cause of Vulnerability:**
The root cause is the use of a broken or risky cryptographic algorithm in the SSL/TLS configuration of Agilia Link+.

**Weaknesses/Vulnerabilities Present:**
- Deficiencies in the SSL/TLS configuration of Agilia Link+.
- The advisory does not specify which algorithm is used but states that it is broken or risky.

**Impact of Exploitation:**
- An attacker may be able to compromise SSL/TLS sessions.
- Eavesdropping on transferred data.
- Manipulating data allegedly secured by SSL/TLS.
- Impersonating an entity to gain access to sensitive information.

**Attack Vectors:**
- Network-based attack.
- An attacker can exploit the vulnerability remotely.

**Required Attacker Capabilities/Position:**
- The attacker needs to be on the network to intercept and manipulate the communications of the affected device.
- No user interaction is required.
- No special privileges are needed to exploit the vulnerability.

**Additional Notes:**
- The affected product is the Agilia Link+ device.
- The vulnerability is assigned a CVSS v3 base score of 6.5.
- The advisory is part of a broader set of vulnerabilities found in the Fresenius Kabi Agilia Connect Infusion System, documented in ICS Medical Advisory ICSMA-21-355-01.